Skin Sealant Protects Against Infections

An innovative microbial barrier is designed to reduce the risk of skin flora contamination during a surgical procedure. The sealant has received the CE mark for sale in the European Union (EU).

InteguSeal microbial sealant, manufactured by Kimberly-Clark Healthcare (Roswell, GA, USA) is easy to apply and fast-drying, and is intended to seal and immobilize pathogens and protect against their migration into the incision. The microbial sealant has a unique mechanism of action that does not promote bacterial resistance and the sealant does not need to be removed for suture or closure. It can be used with a variety of skin-preparation treatments and surgical products such as electrocauterizers, sutures, staples, and wound adhesives. The sealant film bonds to different skin types, irrespective of surface curvature, hair-content, or amount or types of flora present.

"The appropriate use of medical products during surgical procedures can positively impact patient outcomes, which is why we are laser-focused on introducing clinical solutions that help to support our customers' healing mission,” said Joanne Bauer, president of Kimberly-Clark Health Care.

Wound contamination by the patient's endogenous skin flora is a key factor in the development of surgical site infection (SSI), and absolute skin sterilization prior to surgery is not possible. SSIs are a major source of morbidity following operative procedures. Patients who suffer an SSI remain in hospitals up to seven days longer, have a 60% increased probability of admittance to intensive care units (ICUs), are five times more likely to return for continued care within 30 days of discharge, and have double the mortality rate.






Related Links:
Kimberly-Clark Healthcare